Skip to main content

Table 2 Univariable logistic regression analyses of risk factors for in-ICU mortality

From: Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patients

 

OR

95% CI

p Value

Age

1.004

0.98–1.02

0.62

Sex (male)

1.36

0.86–2.17

0.198

SAPS II

1.046

1.028–1.065

< 0.001

SOFA D1

1.24

1.15–1.35

< 0.001

Murray Lung Injury Score

1.14

1.04–1.24

0.003

Onset of septic shock (Intra-ICU)

0.61

0.34–1.06

0.08

Type of admission (Surgical)

0.607

0.37–1.006

0.053

MDR bacteria

2.26

1.18–4.28

0.01

Fungi

2.037

1.14–3.62

0.01

Year of enrollment

0.97

0.91–1.023

0.253

Adequacy of antimicrobial therapy

0.68

0.348–1.328

0.259

Delay in ivIgGAM administration from admission in ICU

1.0039

1.0013–1.0066

0.0035

  1. ivIgGAM Intravenous IgM- and IgA-enriched immunoglobulins; ICU intensive care unit; MDR multidrug resistant; SAPS II Simplified Acute Physiology Score; SOFA D1 sequential organ failure assessment calculated the first day of administration of ivIgGAM